Published in Blood Weekly, December 1st, 2005
Under its license, the BioSpherix Division of Spherix gains the rights to Naturlose-containing products and processes under development at Einstein that enhance storage lifetimes of medicinal proteins, including blood components; Spherix will pay royalties to Einstein on sales of any forthcoming patented products or processes. Spherix will continue funding the Naturlose research at Einstein.
Cooperation between Spherix and Einstein, a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.